Mark Zafereo, Rui Jennifer Wang, Naifa Lamki Busaidy, Ramona Dadu, Priyanka C. Iyer, Steven G. Waguespack, Li Xu, Anastasios Maniakas, Victoria Banuchi, Stephen Yenzen Lai, Steven B. Chinn, Jessica Lyn Geiger, Kathleen Claire Kerrigan, Saad A. Khan, Eric J. Moore, Mabel M. Ryder, Joseph Scharpf, Francis P. Worden, Michelle D. Williams, Maria E. Cabanillas. "Neoadjuvant pembrolizumab in combination with dabrafenib and trametinib (DTP) for
            <i>BRAF</i>
            V600E-mutated anaplastic thyroid cancer (
            <i>BRAF</i>
            m-ATC): A multicenter phase 2 trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.6008